Dopamine in the Turkey retina-an impact of environmental light, circadian clock, and melatonin.
Substantial evidence suggests that dopamine and melatonin are mutually inhibitory factors that act in the retina as chemical analogs of day and night. Here, we show an impact of environmental light, biological clock, and melatonin on retinal levels of dopamine and its major metabolite 3,4-dihydroxyphenylacetic acid (DOPAC) in the turkey. In turkeys held under different light (L) to dark (D) cycles (16L:8D, 12L:12D, 8L:16D), retinal levels of dopamine and DOPAC fluctuated with daily rhythms. High levels of dopamine and DOPAC were observed during light hours and low during dark hours. Under the three photoperiodic regimes, rhythms of dopamine and DOPAC were out of phase with daily oscillation in retinal melatonin content. In constant darkness, dopamine and DOPAC levels oscillated in circadian rhythms. Light deprivation resulted, however, in a significant decline in amplitudes of both rhythms. Injections of melatonin (0.1-1 mumol/eye) during daytime significantly reduced retinal levels of DOPAC. This suppressive effect of melatonin was more pronounced in the dark-adapted than light-exposed turkeys. Quinpirole (a D(2)/D(4)-dopamine receptor agonist; 0.1-10 nmol/eye) injected to dark-adapted turkeys significantly decreased retinal melatonin. Our results indicate that in the turkey retina: (1) environmental light is the major factor regulating dopamine synthesis and metabolism; (2) dopaminergic neurones are controlled, in part, by intrinsic circadian clock; and (3) dopamine and melatonin are components of the mutually inhibitory loop.
Lorenc-Duda
Anna
A
Department of Pharmacology, Medical University of Łódź, Łódź, Poland.
Berezińska
Małgorzata
M
Urbańska
Anna
A
Gołembiowska
Krystyna
K
Zawilska
Jolanta B
JB
D015102:3,4-Dihydroxyphenylacetic Acid / Q000378:metabolism; D000818:Animals; D002492:Central Nervous System Depressants / Q000008:administration & dosage; D002940:Circadian Rhythm; D003624:Darkness; D004298:Dopamine / Q000096:biosynthesis*; D018491:Dopamine Agonists / Q000008:administration & dosage; D008029:Lighting; D008550:Melatonin / Q000008:administration & dosage / Q000096:biosynthesis*; D017440:Photoperiod; D019257:Quinpirole / Q000008:administration & dosage; D012160:Retina / Q000187:drug effects / Q000378:metabolism*; D014422:Turkeys
D002492:Central Nervous System Depressants; D018491:Dopamine Agonists; D015102:3,4-Dihydroxyphenylacetic Acid; D019257:Quinpirole; D008550:Melatonin; D004298:Dopamine